This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Sudeep Pharma IPO Launches
Business initial public offering

Sudeep Pharma IPO Launches

Analysis based on 17 articles · First reported Nov 19, 2025 · Last updated Nov 21, 2025

Sentiment
60
Attention
4
Articles
17
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The Sudeep Pharma IPO is expected to bring new investment opportunities to the market, with strong grey market premiums indicating potential listing gains for investors. The capital raised will support Sudeep Pharma's expansion, potentially increasing its market share and strengthening its position in the specialty chemicals and ingredients sector.

Pharmaceuticals Food and Nutrition Specialty Chemicals
Event Summary

Sudeep Pharma, a manufacturer of specialty chemicals and ingredients for the pharmaceutical, food, and nutrition industries, launched its Initial Public Offering (IPO) on November 21. The IPO, valued at ₹895 crore, includes a fresh issue of ₹95 crore and an offer for sale of approximately 1.35 crore shares by promoters including Sujit Jaysukh Bhayani, Shanil Sujit Bhayani, and Avani Sujit Bhayani. The price band for the shares is set between ₹563 and ₹593. The IPO has seen strong demand, with its grey market premium (GMP) indicating a potential listing price significantly above the issue price. The company plans to use ₹75.81 crore from the fresh issue for capital expenditure, specifically for procuring machinery for its production line at the Nandesari Facility 1 in India — Gujarat, with the remaining funds allocated for general corporate purposes. Sudeep Pharma has a global presence and serves over 1,100 customers, including major players like Pfizer, Mankind Pharma, Merck Group, and Danone. The shares are expected to list on the BSE and the National Stock Exchange of India on November 28.

Entities Involved
priv
Sudeep Pharma
Sudeep Pharma is launching its IPO, which is expected to generate significant capital for expansion and increase its market valuation.
Importance 100.0 Sentiment 70.0
priv
Si Creva Capital Services
Si Creva Capital Services is one of the book-running lead managers for the Sudeep Pharma IPO, playing a role in its execution.
Importance 40.0 Sentiment 20.0
priv
Link Intime India Private Limited
Link Intime India Private Limited is the registrar for the Sudeep Pharma IPO, handling the share allotment process.
Importance 30.0 Sentiment 10.0
per
Sujit Jaysukh Bhayani
Sujit Jaysukh Bhayani is a promoter offering shares in the Sudeep Pharma IPO.
Importance 20.0 Sentiment 10.0
per
Shanil Sujit Bhayani
Shanil Sujit Bhayani is a promoter offering shares in the Sudeep Pharma IPO.
Importance 20.0 Sentiment 10.0
per
Avani Sujit Bhayani
Avani Sujit Bhayani is a promoter offering shares in the Sudeep Pharma IPO.
Importance 20.0 Sentiment 10.0
stock
Aurobindo Pharma
Aurobindo Pharma is a marquee customer of Sudeep Pharma.
Importance 10.0 Sentiment 5.0
subs
IMCD — IMCD Asia
IMCD — IMCD Asia is a global distributor and a marquee customer of Sudeep Pharma.
Importance 10.0 Sentiment 5.0
priv
Cadila Pharmaceuticals
Cadila Pharmaceuticals is a marquee customer of Sudeep Pharma.
Importance 10.0 Sentiment 5.0
stock
Mankind Pharma
Mankind Pharma is a marquee customer of Sudeep Pharma, highlighting its strong client relationships.
Importance 10.0 Sentiment 5.0
stock
Danone
Danone is a marquee customer of Sudeep Pharma, particularly in the food and nutrition sector.
Importance 10.0 Sentiment 5.0
stock
Merck Group
Merck Group is a marquee customer of Sudeep Pharma, demonstrating its global presence.
Importance 10.0 Sentiment 5.0
exch
BSE
Importance 0.0 Sentiment 0.0
loc
India — Gujarat
Importance 0.0 Sentiment 0.0
exch
National Stock Exchange of India
Importance 0.0 Sentiment 0.0
+ 2 more entities View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.